The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era Publisher

Akhondzadeh S¹ ; Shamabadi A¹

Source: Avicenna Journal of Medical Biotechnology Published:2021

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2024)

2. The Need for Serious Support for Basic Medical Science in Iran, Avicenna Journal of Medical Biotechnology (2024)

3. Basic Science and Clinical Studies on Non-Covid-19 Topics, of Coronavirus Victims, Avicenna Journal of Medical Biotechnology (2020)

Experts (# of related papers)

View all Related Experts

Shahin Akhondzadeh Basti (11)

Mohammad Reza Mohammadi (1)

Other Related Docs

4. Pentoxifylline Adjunct to Risperidone for Negative Symptoms of Stable Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial, International Journal of Neuropsychopharmacology (2025)

5. L-Carnosine As an Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, Psychiatry Research (2018)

6. Palmitoylethanolamide As Adjunctive Therapy for Autism: Efficacy and Safety Results From a Randomized Controlled Trial, Journal of Psychiatric Research (2018)

7. Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran, BMC Medical Ethics (2025)

8. Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production, Avicenna Journal of Medical Biotechnology (2021)

9. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)

10. Herbal Medicine in the Treatment of Schizophrenia: A Review, Journal of Medicinal Plants (2018)

11. The Role of Biotechnology in Latest Therapeutic Approaches for Diabetes Mellitus, Avicenna Journal of Medical Biotechnology (2024)

12. Efficacy and Safety of Adjunctive Therapy With Fingolimod in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Schizophrenia Research (2023)

Style	Citing Format
MLA	Akhondzadeh S, Shamabadi A. "The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era." Avicenna Journal of Medical Biotechnology, vol. 13, no. 2, 2021, pp. 53-.
APA	Akhondzadeh S, Shamabadi A (2021). The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era. Avicenna Journal of Medical Biotechnology, 13(2), 53-.
Chicago	Akhondzadeh S, Shamabadi A. "The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era." Avicenna Journal of Medical Biotechnology 13, no. 2 (2021): 53-.
Harvard	Akhondzadeh S, Shamabadi A (2021) 'The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era', Avicenna Journal of Medical Biotechnology, 13(2), pp. 53-.
Vancouver	Akhondzadeh S, Shamabadi A. The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era. Avicenna Journal of Medical Biotechnology. 2021;13(2):53-.
BibTex	@article{ author = {Akhondzadeh S and Shamabadi A}, title = {The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era}, journal = {Avicenna Journal of Medical Biotechnology}, volume = {13}, number = {2}, pages = {53-}, year = {2021} }
RIS	TY - JOUR AU - Akhondzadeh S AU - Shamabadi A TI - The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era JO - Avicenna Journal of Medical Biotechnology VL - 13 IS - 2 SP - 53 EP - PY - 2021 ER -